Klaus Klumpp
Corporate Officer/Principal bei Novira Therapeutics LLC
Profil
Klaus Klumpp is currently working as Vice President-Discovery at Novira Therapeutics LLC.
Prior to this, he worked as Principal at The European Molecular Biology Laboratory and Wellcome Research Laboratories.
Aktive Positionen von Klaus Klumpp
| Unternehmen | Position | Beginn |
|---|---|---|
Novira Therapeutics LLC
 Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Klaus Klumpp
| Unternehmen | Position | Ende |
|---|---|---|
| The European Molecular Biology Laboratory | Corporate Officer/Principal | - |
| Wellcome Research Laboratories | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Novira Therapeutics LLC
Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Health Technology |
| Wellcome Research Laboratories |
